Abstract
IN an earlier communication we reported that rats fed a diet containing 2 per cent of DL-α-guanidinopropionic acid (alacreatine) develop weakness during a 6-week period1. In subsequent work we have been unable to demonstrate either a defect in creatine metabolism in these animals or improvement of the weakness by creatine administration. Because of an odour which suggested the presence of a sulphur-containing compound in the alacreatine preparation further experiments were done with highly purified odourless alacreatine. None of the animals receiving the purified alacreatine became weak. It thus appears that the weakness was not caused by alacreatine, but by an impurity. The impurity has not been identified. However, various isothiourea and guanidine derivatives are known to be toxic in acute dose2 and such compounds could have been present in the original preparations of alacreatine.
Similar content being viewed by others
Article PDF
References
Fitch, C. D., and Dinning, J. S., Nature, 187, 421 (1960).
Guggenheim, M., Die biogenen Amine, 386 (S. Karger, Basel, 1951).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
FITCH, C., DINNING, J. Effect of Alacreatine on the Rat. Nature 198, 1003 (1963). https://doi.org/10.1038/1981003a0
Issue Date:
DOI: https://doi.org/10.1038/1981003a0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.